CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/9944

Title:	CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)
Authors:	Musakov Mirzokhid Sabitdjanovich, Samatova Lobar Dilmurodovna, Turaxojaeva Sabokhat Sultanshikovna, Salaeva Muborak Saidabdullayevna, Tursunova Minavvar Ulug’bekovna
Keywords:	antiphospholipid syndrome (APS), antiphospholipid antibodies, lupus anticoagulant.
Issue Date:	May-2023
Publisher:	Spectrum Journal of Innovation, Reforms and Development
Abstract:	Antiphospholipid syndrome (APS) is one of the leading causes of thrombosis. According to some estimates, the incidence of APS is about 5 new cases per 100,000 people per year and the prevalence is about 40-50 cases per 100,000 people [1], thus the problem of APS remains one of the most important in medicine.
URI:	http://repository.tma.uz/xmlui/handle/1/9944
ISSN:	2751-1731
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
10-174 Статья инглиз.pdf		298.72 kB	Adobe PDF	View/Open

DSpace JSPUI